Author:
Wang Tianqi,Ding Guixin,Wang Xiaoyu,Cui Yuanshan,Ma Xiaohong,Ma Jian,Wu Jitao
Funder
Taishan Scholar Foundation of Shandong Province
Taishan Scholar Project of Shandong Province
Natural Science Foundation of Shandong Province
National Natural Science Foundation of China
Reference60 articles.
1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023
2. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Powles;Ann Oncol,2022
3. Treatment of muscle-invasive and advanced bladder cancer in 2020;Patel;CA Cancer J Clin,2020
4. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial;Powles;Lancet Oncol,2021
5. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial;Galsky;Lancet (London, England),2020